Teligent Pharma, Inc. is recalling approximately 62,040 tubes of Lidocaine Ointment USP, 5% (generic lidocaine). This prescription topical medication was found to fail stability specifications because it did not meet required viscosity (thickness) results during testing. Because the ointment may not have the correct consistency, it may not perform as expected or could lead to inconsistent dosing. Consumers should consult their healthcare provider or pharmacist regarding the continued use of this product.
The product failed to maintain its required thickness (viscosity) over time, which can affect how the medication is applied and absorbed by the skin, potentially leading to ineffective treatment of the intended area.
Contact healthcare provider and return to pharmacy
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.